Structural Biology and Biochemistry of Coronavirus

NIH Pandemic-Era Grants

Pandemic Era Grants

2023

↗ Live URL (may be dead)

Document text

Principal Investigator: Audray  Harris
Organization: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Fiscal Year: 2023
Award: $5,807
Funding agency: National Institute of Allergy and Infectious Diseases

Coronaviruses remain both a seasonal health burden and pandemic threat due to the antigenic variation of viral glycoproteins and the ability of animal coronaviruses to cause zoonotic infections in humans. Although conserved epitopes have been identified, there is a fundamental gap in understanding and correlating the disposition of conserved coronavirus epitopes on subunit vaccines and designed nanoparticles with immunogenicity. Lack of such information represents important problems and until they are addressed optimal display of conserved coronavirus epitopes cannot be understood in molecular details. In FY 2023, we established milestones for the expression and purification of structure-based immunogens in order to produce chimeric proteins that carry antigenically conserved epitopes from coronaviruses. These designed chimeric protein antigens will assist in understanding how to optimize the display and immunogenicity of conserved coronavirus epitopes on vaccine platforms. This work is significant and relevant to public health because information on how to increase the elicited protective immune responses to conserved coronavirus epitopes will aid in the development of more efficacious vaccines to different antigenic variants of coronaviruses. This is important because coronaviruses can be both seasonal and pandemic viruses in the human population.

Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><3-D><3-Dimensional><3D><Address><Affect><Animals><Antibodies><Antigen Variation><Antigenic Determinants><Antigenic Variability><Antigenic Variation><Antigens><Architecture><B blood cells><B cell><B cells><B-Cells><B-Lymphocytes><B-cell><Binding><Binding Determinants><Biochemical><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 public health crisis><COVID-19 virus><COVID19 crisis><COVID19 epidemic><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 pandemic><COVID19 public health crisis><COVID19 virus><Chimera Protein><Chimeric Proteins><CoV S protein><CoV glycoprotein S><CoV spike glycoprotein><CoV spike protein><CoV-2><CoV2><Coin><Communicable Diseases><Competence><Complex><Coronaviridae><Coronavirus><Coronavirus glycoprotein S><Coronavirus spike protein><Development><Disease><Disorder><Electron Microscopy><Encapsulated><Engineering / Architecture><Epitopes><Formulation><Fusion Protein><Genome><Geometry><Glycoproteins><Goals><Health><Human><Immune response><Immune system><Immunochemical Immunologic><Immunologic><Immunological><Immunological response><Immunologically><Immunologics><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Innate Immune Response><MERS><MERS coronavirus disease><MERS-CoV disease><Membrane><Membrane Protein Gene><Membrane Proteins><Membrane-Associated Proteins><Middle East Respiratory Syndrome><Middle East Respiratory Syndrome CoV disease><Middle East Respiratory Syndrome coronavirus disease><Middle Eastern Respiratory Syndrome><Middle Eastern Respiratory Syndrome CoV disease><Middle Eastern Respiratory Syndrome coronavirus disease><Mission><Modern Man><Molecular><Molecular Interaction><Molecular Modeling Nucleic Acid Biochemistry><Molecular Modeling Protein/Amino Acid Biochemistry><Molecular Models><NIH><Nanoplatform><Nanotechnological platform><National Institutes of Health><Nucleocapsid Proteins><Phase><Population><Proteins><Public Health><Recombinants><Research><SARS Virus><SARS corona virus><SARS corona virus 2><SARS coronavirus><SARS-Associated Coronavirus><SARS-CO-V2><SARS-COVID-2><SARS-CoV><SARS-CoV-1><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-CoV2><SARS-CoV2 epidemic><SARS-CoV2 pandemic><SARS-Related Coronavirus><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Scaffolding Protein><Seasons><Severe Acute Respiratory Coronavirus><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome related corona virus 2><Structural Biochemistry><Structure><Subunit Vaccines><Surface Proteins><T-Cell Epitopes><T-Cells><T-Lymphocyte><T-Lymphocyte Epitopes><Testing><United States National Institutes of Health><Vaccine Production><Vaccines><Variant><Variation><Viral><Viral Structural Proteins><Viral Vaccines><Virion><Virus><Virus Particle><Work><Wuhan coronavirus><Zoonoses><Zoonotic><Zoonotic Infection><adaptive immune response><animal coronavirus><arm><corona virus><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><coronavirus S protein><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 virus><coronavirus spike glycoprotein><design><designing><developmental><hCoV19><host response><immune system response><immunogen><immunogenicity><immunoresponse><innovate><innovation><innovative><membrane structure><molecular modeling><nCoV2><nano particle><nano-sized particle><nanoparticle><nanosized particle><nanotechnology platform><neutralizing antibody><pan CoV vaccine><pan coronavirus vaccine><panCoV vaccine><pancoronavirus vaccine><pandemic concern><pandemic potential><pandemic risk><pandemic threat><pandemic virus><particle><produce vaccines><scaffold><scaffolding><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome-CoV><structural biology><structural glycoprotein><structural-GP><three dimensional><thymus derived lymphocyte><universal CoV vaccine><universal coronavirus vaccine><vaccine antibodies><vaccine efficacy><vaccine formulation><vaccine induced antibodies><vaccine platform><vaccine-induced antibodies><viral RNA><virus RNA>